Papillary Renal Cell Carcinoma - 26 Studies Found
Not yet recruiting |
: Savolitinib vs. Sunitinib in MET-driven PRCC :
: |
Recruiting |
: Cabozantinib-S-Malate, Crizotinib, Volitinib, or Sunitinib Malate in Treating Patients With Locally Advanced or Metastatic Kidney Cancer :
: |
Active, not recruiting |
: Bevacizumab With or Without TRC105 in Treating Patients With Metastatic Kidney Cancer :
|
Completed |
: Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer : Intraabdominal Cancers (Various Types) : 2006-01-26 : Biological: Cancer Macrobead placement in abdominal cavity 8 macrobeads per kg |
Recruiting |
: Nonrandomized, Open-Label Phase IIb Efficacy Trial of Cancer Macrobeads Compared With Best Supportive Care in Patients With Treatment-Resistant Colorectal Cancer : Colorectal Cancers : 2014-01-21 : Biological: RENCA macrobeads Other Names:
|
Recruiting |
: Open-Label Phase 2 Efficacy Trial of Cancer Macrobeads in Patients With Treatment-Resistant Pancreatic or Colorectal Cancer :
: 2010-01-20 : Biological: Cancer macrobead placement in abdominal cavity 8 macrobeads per kilogram |
Completed |
: TroVax Renal Immunotherapy Survival Trial : Clear Cell Renal Carcinoma : 2006-11-08 : Biological: Trovax 1ml IM injection 2-8 weeks apart. |
Terminated |
: Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer :
|
Recruiting |
: CREATE: Cross-tumoral Phase 2 With Crizotinib :
|
Active, not recruiting |
: Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant :
|